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Abstract  
Objective: Glucocorticoids (GC) are indicated for a number of conditions in obstetrics and perinatal 
medicine; however, the neurodevelopmental and long-term neurological consequences of early-life GC 
exposure are still largely unknown. Preclinical studies have demonstrated that GC have a major 
influence on hippocampal cell turnover by inhibiting neurogenesis and stimulating apoptosis of mature 
neurons. Here we examined the fate of the limited pool of neural progenitor cells (NPC) after GC 
administration during neonatal development; the impact of this treatment on hippocampal structure was 
also studied.  
Methods: Phenotype-specific genetic and antigenic markers were used to identify cultured NPC at 
various developmental stages; the survival of these cells was monitored after exposure to the synthetic 
glucocorticoid dexamethasone (DEX). In addition, the effects of neonatal DEX treatment on the 
neurogenic potential of the rat hippocampus were examined by monitoring the incorporation of 
bromodeoxyuridine and expression of Ki67 antigen at various postnatal ages.  
Results: Multipotent nestin-expressing NPC and Tα1-tubulin-expressing immature neurons succumb 
to GC-induced apoptosis in primary hippocampal cultures. Neonatal GC treatment results in marked 
apoptosis among the proliferating population of cells in the dentate gyrus, depletes the NPC pool, and 
leads to significant and sustained reductions in the volume of the dentate gyrus.  
Interpretation: Both NPC and immature neurons in the hippocampus are sensitive to the pro-apoptotic 
actions of GC.  Depletion of the limited NPC pool during early life retards hippocampal growth, thus 
allowing predictions about the potential neurological and psychiatric consequences of neonatal GC 
exposure.  
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Introduction  
Acquisition and loss of hippocampal neurons are implicated in the regulation of cognition, mood 
and neuroendocrine function.1-4 Most likely, the availability of hippocampal neurons determines 
neuroplastic changes in the intra-hippocampal circuitry as well as connectivity between the 
hippocampus and other cortical and sub-cortical areas.5 The subgranular zone (SGZ) of the 
hippocampal dentate gyrus is endowed with a pool of neural precursor cells (NPC) which can divide and 
differentiate into either neurons or glial cells.2, 6 Newly-generated neurons integrate into existing 
hippocampal circuits6 and facilitate learning and memory.2-4 Neurogenesis tapers off over lifetime and is 
regulated by intrinsic (e.g. age7, 9) and extrinsic signals (e.g. stress10, 11) whose actions are mainly 
mediated by GC. Since the size of the NPC pool is a potentially important determinant of life-long 
hippocampal function, there is considerable interest in the link between lifetime neurogenesis and 
cognitive deficits that result from exposure to high GC levels.12, 13  
The synthetic glucocorticoid receptor (GR) agonist, dexamethasone (DEX), is commonly used in 
obstetrics and neonatal medicine. Previously, we demonstrated that DEX induces cell cycle arrest14 and 
apoptosis15-17 in mature neurons of the dentate gyrus. In this study, we addressed the question of 
whether DEX can directly influence the survival of NPC. In addition, we tested the hypothesis that 
neonatal DEX administration permanently depletes the neurogenic pool. Our results show that GC 
target NPC for apoptosis and that neonatal GC markedly reduces the number of NPC available for the 
generation of new neurons.  
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Materials and methods 
Drugs and plasmids: Dexamethasone (DEX; Fortecortin™; Merck, Darmstadt, Germany), was added to 
cultures for 48 h (24 h after transfection). The GR antagonist, RU38486 (10 µM; NHPP, Torrance, CA) 
was added 1 h before DEX application. Mitotic cells were labeled (24 h) with 5-bromo-2′-deoxyuridine 
(BrdU; 20 µM; Sigma, St. Louis, MO). The specific caspase 3 and 9 inhibitors, Ac-DEVD-cmk (1 µM) 
and Ac-LEHD-cmk (30 µM), were obtained from Calbiochem (Schwalbach, Germany) and applied 30 
min before addition of DEX.  
Neural precursor cells (NPC), neural progenitors and astrocytes were labeled with 
pBSIISK-E/Nestin-EGFP,18 pBSII SK-Tα1-GFP19, and pGFAP-GFP20 (courtesy of Drs. Hideyuki Okano, 
Freda Miller, and Helmut Kettenmann, respectively) . 
Primary hippocampal cultures and transfection: Hippocampal cultures were prepared from Wistar 
rats (Charles River, Sulzfeld, Germany) on postnatal day (PND) 4, and transfected (~ 10% efficiency) 5 
days after plating.16  
Animals and tissues: EU and NIH guidelines on animal care and experimentation were observed. 
Forty-eight male Wistar rats were housed under standard laboratory conditions. Rats received s.c. 
injections of either vehicle (saline) or DEX on PND1-7 (DEX 200 µg/kg/d on PND1-3; 100 µg/kg/d on 
PND 4-7). All animals received a single i.p. injection of BrdU (50 mg/kg) 24 h before killing on PND10, 
18 or 28. Serial coronal cryosections (20 µm), extending over the entire length of the hippocampal 
formation, were cut and mounted before sequential double-staining of every 8th section with antibodies 
against BrdU (1:200; DAKO, Hamburg, Germany) and Ki67 (1:500, Biotrend, Cologne, Germany); cell 
nuclei were counterstained with Hoechst 33342 (1 µg/ml, 10 min).  
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Immunocyto- and histochemistry: Cells or sections were fixed (4% paraformaldehyde), 
permeabilized (0.3% Triton-X100/PBS), blocked and incubated (4oC) with anti- BrdU (after treatment 
with 2 N HCl), nestin (1:1000; Millipore, Goettingen, Germany), -TuJ1 (1:500; Babco, Richmond, CA), 
-MAP2 (1:500; Sigma), -doublecortin (1:500; Santa Cruz, Heidelberg, Germany), -GFAP (1:1500; 
DAKO or 1:4,000, Sigma), -NeuN (1:500; Millipore), -O4 (1:500; Millipore), -GR (1:300; M20, Santa 
Cruz), -Sox2 (1:300, Santa Cruz), cleaved caspase 3 (1:200; Cell Signaling/NEB, Frankfurt, Germany) 
and p47-phox (1:200, Millipore). Immunoreactivity was visualized using appropriate Alexa 
Fluor-conjugated secondary antibodies (1:500; Invitrogen). Cells were analyzed (ImagePro software, 
Media Cybernetics, Bethesda, MD) on an Olympus BX-60 microscope. Cell counts were performed on 
10 individual microscopic fields (0.072 mm2), randomly chosen across two diameters of each coverslip 
(400X magnification). An average of 1,000 cells or 100 transfected cells was sampled on each coverslip; 
results shown represent values from 6-9 coverslips/treatment.  
Apoptotic cells were identified by TUNEL histochemistry (with FITC- or Texas Red-conjugated avidin; 
Vector, Burlinghame, CA), immunostaining for cleaved (active) caspase 3, or Hoechst 33342 staining. 
Those cells showing morphologocal signs of DNA fragmentation17, 21 were considered to be apoptotic.  
Stereology: StereoInvestigator (MicroBrightField, Williston/VT) was used to estimate the volumes of 
different subdivisions of the dentate gyrus and cell densities (NV) in the subgranular zone (SGZ) of the 
dentate gyrus. The total number of BrdU+ or Ki67+ NPCs in the SGZ was derived from the product of Nv 
and total SGZ volume. To identify BrdU and Ki67 double-stained cells, sections were examined (XY, YZ 
and XZ views) by confocal microscopy (Olympus IX81 LSM, Hamburg, Germany).  
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Statistics: Numerical data (shown as mean + SEM) were subjected to 2-tailed Student´s t-tests or 
ANOVA and appropriate post-hoc analysis (SPSS Inc, Chicago, IL). The level of significance was 
preset at p < 0.05. 
 
Results  
Phenotypic identity and GR expression in hippocampal cultures 
After 6 days in vitro (DIV), hippocampal cultures expressed markers specific to NPC (~40% nestin+) and 
immature neurons (~35% TuJ1+ and DCX+); approximately 10% of the cells were young neurons 
(NeuN+), and 15% were astrocytes (glial fibrillary acidic protein [GFAP]+) or oligodendrocytes (O4+) (Fig 
1A). Immunoreactive GR was detectable in NPC and immature/young neurons (Fig 1B and Fig. 1C). 
GR expression was observed in ~45% of nestin-GFP-transfected NPC and ~65% of Tα-tubulin-GFP 
labeled immature neurons (Fig 1B); stimulation with DEX resulted in translocation of immunoreactive 
GR to the nucleus, suggestive of its transcriptional potential (Fig 1B, inset). Treatment of cultures with 
DEX resulted in a dose-dependent induction of apoptosis that was preventable by pre-treatment with 
the GR antagonist RU38486 (Fig 1D); since consistently robust effects were observed at a dose of 10-5 
M, this dose was chosen for all subsequent in vitro experiments.  
 
Regulation of NPC and post-mitotic hippocampal cell fate by GC 
Neuroplasticity depends on the availability of NPC.6 While neurogenesis is implicated in recovery from 
stroke,22 reduced proliferative capacity of hippocampal cells is associated with epilepsy,23 impaired 
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cognition2 and depression.24, 25 We show here that DEX reduces the number of immunocytochemically 
identified NPC (by ~39%), neuroblasts (~39%) and immature neurons (~54%) (P < 0.05, in all cases; 
Fig. 2A).  
We previously demonstrated that GC induce apoptosis in hippocampal cells in culture16, 17 and that  
GC-induced apoptosis in situ is prominent in the SGZ where NPC reside and proliferate.21, 26 To 
examine the hypothesis that apoptosis leads to a reduction in NPC and immature neuron numbers, we 
next treated hippocampal cultures with the cytosine analog bromodeoxyuridine (BrdU, to reveal recently 
proliferated cells27) and DEX for 24 h before quantifying apoptosis (identified by TUNEL or activated 
caspase 3 immunoreactvity) in recently-proliferated (BrdU-labeled27) cells. As compared to untreated 
cells (Fig 2B1-2B5), DEX-treated cells showed greater co-localization of BrdU and TUNEL signals (Fig 
2C1-2C5). Evaluation of individual merged images revealed significantly increased apoptosis among 
both mitotic (BrdU+: CON: 8.4 ± 3.4%; DEX: 17.8 ± 5.0%; P < 0.05) and resting (BrdU-: CON: 27.6 ± 
3.0%; DEX: 41.0 ± 4.1%; P < 0.05) cell populations after GC treatment (Fig 2D). The results obtained 
with TUNEL histochemistry were corroborated by cleaved (activated) caspase 3 immunocytochemistry 
(Fig 2E). 
 
Phenotype-specificity of the apoptotic actions of GC 
NPC proliferate and differentiate along either neuronal or glial lineages.6 Given the intrinsic 
characteristics of NPC and the heterogeneous nature of primary hippocampal cultures (Fig 1), we here 
analyzed the cell phenotypes targeted for GC-induced apoptosis in mixed hippocampal cultures 
transfected with specific plasmids that would facilitate distinction between NPC (nestin-EGFP) and 
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neuronal progenitors (Tα1-GFP). Exposure of cells to DEX produced a significant increase in 
TUNEL-labeled apoptotic cells among the NPC (Fig 3A-C, 3G-I and 3U; P < 0.05) and neuronal 
progenitor (Fig 3D-F, 3J-L and 3U; P < 0.05) cell populations; the TUNEL results were confirmed by 
staining for cleaved (activated) caspase 3 immunoreactivity (Fig 3M-P, 3Q-T and 3V; P < 0.05). In all 
cases, the apoptotic actions of DEX were attenuated when cells were pre-treated with the GR 
antagonist RU 38486, indicating their mediation by GR (Fig 3U, 3V). Interestingly, astrocytes marked 
with GFAP-GFP did not succumb to the apoptotic effects of DEX (Fig 3U).  
 
Mitochondrial mechanisms mediate GC-induced apoptosis in NPC 
 The data showing that DEX treatments leads to an activation of caspase 3 (Fig 2E, Fig 3M-3T, 3U, 
3V, and Fig 5B-D) in NPC hinted at involvement of the mitochondrial or ‘instrinsic’ pathway of 
apoptosis.15 These findings were confirmed in hippocampal cultures using pharmacological inhibitors of 
caspase 3 and its upstream caspase, caspase 9 (Fig 4A). Examining events upstream of the caspases, 
we observed that DEX treatment dose-dependently increases the ratio of pro-apototic bax to 
anti-apoptotic bcl-2 mRNA expression, without influencing the bax:bclXL mRNA expression ratio (Fig 4B); 
the latter findings are consistent with the fact that the predominant anti-apoptotic protein in developing 
neurons is Bcl-2 rather than BclXL.26 
 The mitochondrial proteins Bax and Bcl-2 act in a rheostatic manner to regulate the integrity of the 
mitochondrial permeability transition which is particularly sensitive to perturbation by reactive oxygen 
species (ROS). Measurement of ethidium intercalation into DNA showed that ROS generation 
represents a mechanism through which DEX induces apoptosis (Fig 4C). Additionally, DEX stimulates 
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ROS production in NPC (Fig 4D and Fig 4E); this effect is accompanied by a translocation of 
membrane-associated p47phox (an essential component of the nicotinamide adenine dinucleotide 
phosphate [NADPH] oxidase [Nox] complex  required for the production of superoxide anions) (Fig 4F) 
and reductions in the activities of Cu++/Zn++superoxide dismutase and glutathione, two key anti-oxidant 
enzymes (Fig 4G).  
 
Depletion of the NPC pool by GC treatment during peak neurogenesis in vivo 
Hippocampal neurogenesis occurs at a high frequency during early postnatal life.28 However, NPC 
have limited self-renewal capacity29 and the NPC pool from which new neurons are generated 
diminishes exponentially with age;7, 9 GC are thought to at least partially contribute to the latter 
phenomenon.8 On the other hand, proliferating hippocampal cells were previously reported to express 
GR only sparsely.30 As shown in Fig 5A, numerous cells in the neonatal dentate gyrus express GR 
along a gradient that increases from the SGZ to the inner layers of the GCL where more mature granule 
neurons are localized. Importantly, DEX treatment provoked a 60% increase in apoptosis (increase in 
active caspase 3 immunoreactivity) in the SGZ (Fig 5B-D; P < 0.05). Two types of NPC are found in the 
SGZ: quiescent neural precursors (QNP; GFAP-positive, proliferate relatively slowly) and amplifying 
neural precursors (ANP; GFAP-negative, display high proliferative activity).31 Accordingly, it was 
considered important to investigate if QNP and ANP might be differentially sensitive to glucocorticoids. 
Both QNP and ANP express nestin and Sox2, but whereas nestin levels in ANP diminish over time, 
Sox2 expression is maintained at relatively steady levels in both NPC subtypes and serves as a more 
reliable marker of NPC (QNP: GFAP+/Sox2+; ANP: GFAP-/Sox2+). Exploiting these characteristics, 
Page 9 of 32
John Wiley & Sons
Annals of Neurology
 10 
co-localization studies showed that a similar proportion of QNP and ANP express GR (Suppl Fig 
S1A-S1C), suggesting their similar vulnerability to DEX.  
We subsequently assessed the impact of neonatal GC administration on the proliferative capacity 
of the dentate gyrus in later life by performing stereological counts of the number of BrdU- and 
Ki67-stained cells in the SGZ of PND10, 18 and 28 days (Fig 6A-C). The results of this analysis 
revealed that neonatal treatment with DEX results in a significant reduction in the number of cells 
available for mitosis at any given time (P < 0.05; Fig 6D), suggesting a depletion of the NPC pool by 
neonatal DEX. Interestingly, the absolute differences between the number of proliferating cells in the 
SGZ of both control and DEX-treated rats diminished over time (but remained significantly different), 
probably reflecting age-related decreases in proliferative activity (Fig 6D) and the fact that a 
sub-population of NPC that do not express GR (see Suppl Fig S1) may escape the apoptotic actions of 
neonatal GC treatment. 
Since expansion of the GCL occurs primarily during early postnatal life, we next carried out a 
stereological assessment of the volumes of the SGZ and GCL. This analysis revealed that SGZ 
volumes of DEX-treated animals were significantly smaller (P < 0.05), despite similar volumetric 
increments over time (14-20%) (Fig 6E); the latter suggests proliferation by residual NPC that were 
spared from the apoptotic effects of neonatal DEX. While both controls and DEX-treated animals 
showed significant increases in the volumes of their GCL between the ages of 10 and 28 days (Fig 6E, 
P < 0.05), GCL volumes in the DEX-treated animals were significantly smaller than in controls (Fig 6E, 
P < 0.05). In sum, these results suggest that reduced neurogenesis and subsequently, reduced cell 
acquisition in the GCL, result in a marked retardation of GCL development in animals exposed to 
neonatal DEX (Fig 6E). 
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Discussion  
Several neurological and psychiatric disorders are hallmarked by hippocampal dysfunction. The 
last decade has witnessed compelling evidence for a link between hippocampal function and cell 
turnover in the postnatal hippocampus.6, 13, 24, 25, 32 Neuronal turnover in the hippocampus is a dynamic 
process involving neurogenesis and apoptosis in the germinative layer (SGZ) of the dentate gyrus;3 
stress and elevated GC levels inhibit neurogenesis and stimulate apoptosis in the hippocampus.11, 12, 21, 
26
 While GC are known to interfere with the neural cell cycle,14 it is not known whether GC target NPC for 
apoptosis. Accordingly, we here examined the incidence of apoptosis in hippocampal cultures that were 
genetically marked with developmental phase-specific markers to identify proliferating multipotent NPC 
and NPC destined to become neurons. In addition, we studied the consequences of neonatal treatment 
with DEX, a synthetic GC (when neurogenesis and apoptosis occur at high frequency28) on dentate 
gyrus development in situ.  
The presented results demonstrate that both NPC and neuronal progenitors are subject to 
DEX-induced apoptosis. The actions of DEX were shown to be mediated by GR which are expressed by 
NPC, neuronal progenitors and mature neurons (in culture) and by QNP and ANP cells residing in the 
SGZ; notably, the SGZ displays a prominent apoptotic response to DEX. It is important to note, however, 
that since GR expression by NPC is not ubiquitous, a sub-population of NPC may be (at least transiently) 
spared from the actions of DEX. However, given the finite self-renewing properties of NPC,29 disruption 
of the lifelong cycle of neuronal birth and therefore, sustained deleterious effects on hippocampal 
growth and function, is a plausible scenario being investigated in a long-term study. Meanwhile, 
analysis of the mechanisms through which DEX induces NPC apoptosis revealed a role for the 
mitochondrial pathway. Consistent with previous findings,33 our results indicate that the pro-apoptotic 
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actions of DEX are initiated by an increase in ROS levels and concomitant decreases in the cellular 
defenses against oxidative stress. Through their disruption of the mitochondrial membrane potential, 
these events subsequently lead to activation of caspase 9 and caspase 3. Notably, we show that DEX 
treatment results in increased activation of the ‘executor caspase’, caspase 3, in NPC in culture and in 
the SGZ of the intact hippocampus. 
The capacity of the hippocampus to produce new neurons declines markedly with age.7-9, 34 While 
previous work reported an 80% decrease in the neurogeneic capacity of the hippocampus between 1 
and 22 months of age,7-9, 34 our results show an even steeper decline (~92%) between PND10 and 28. 
Thus, the hippocampus undergoes its most dynamic structural organization during the early postnatal 
period, with a precipitous depletion of the NPC pool9 that probably reflects changes in the milieu that 
normally encourages NPC proliferation.35 Given that NPC are vulnerable to the apoptotic actions of 
DEX (this study),and have a limited capacity for self-renewal,29 as well as the fact that the dentate gyrus 
increases in neuronal number and volume for at least 1 year,36  it was considered important to examine 
whether DEX influences the in vivo NPC pool in a transient or sustained fashion. We observed that 
neonatal DEX treatment induces a sustained reduction in the number of mitotic cells and, importantly, 
retards the volumetric growth of the SGZ and GCL. This finding is consistent with previous reports in 
rats and rhesus monkeys.37-39 On the other hand, postnatal neurogenesis and granule cell volumes 
appear to be unaltered by prenatal exposure to DEX40 and neurogenesis is only transiently inhibited 
when DEX is administered to adults.41 These observations suggest that early postnatal life may 
represent a window during which NPC are particularly sensitive to DEX and that exposure to DEX 
during this period results in a protracted retardation of dentate gyrus development.  
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The paradigm of chronic DEX administration during perinatal life is clinically relevant; there is 
convincing evidence that glucocorticoids during early childhood lead to impairments of neuromotor 
functions and cognition, as well as head and somatic growth .42, 43 This study shows that the 
hippocampus endures increased levels of neuronal apoptosis, retarded growth and sustained 
reductions in the rate of neurogenesis when DEX is administered during neonatal life; moreover, an 
earlier study associated such treatment with reduced forebrain expression of synaptic proteins and 
disruption of the ontogeny of neurotransmitter systems.37 Since lifetime cognitive performance relies on 
plasticity (including neurogenesis) in the hippocampus,2, 4, 6, 34 the sustained depletion of the NPC pool 
by neonatal DEX is likely to have a major impact on lifetime learning and memory. Lastly, early-life 
experiences that stimulate endogenous glucocorticoid secretion and interfere with neuroplasticity are 
established etiopathogenic factors in a number of psychiatric conditions, best exemplified by major 
depression.1, 13     
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Titles and legends to figures 
 
Fig 1.  Immature hippocampal cells are sensitive to glucocorticoids. 
(A) After 7 days in vitro (DIV), primary hippocampal cultures, derived from postnatal rats aged 4 days, 
were comprised of ~ 40% neural precursor cells (NPC, labeled with anti-nestin) and ~ 35% immature 
neurons (stained with anti-TuJ1 or -doublecortin [DCX]; <10% of the cells stained with anti-NeuN, a 
marker of young neurons (NeuN), and <20% of the cells were astrocytes and oligodendrocytes (stained 
with antibody O4). (B) Immunoreactive glucocorticoid receptor (GR) was localized in both NPC and 
neuronal progenitors; shown are the percentage of GR-expressing cells in the different cell populations. 
NPC (nestin-positive cells identified by immunocytochemistry or cells transfected with nestin-GFP) and 
immature neurons (stained with anti-DCX or -TuJ1, or transfected with Tα-tubulin-GFP), as well as 
neurons (stained with anti-NeuN). The inset is an example of an immunoblot of cytoplasmic and nuclear 
fractions probed with GR antibody; note the increased GR signal in the nucleus (vs. cytoplasm) in 
lysates from cells that had been treated with glucocorticoid (dexamethasone, DEX, 10-5 M). (C) 
Representative images of nestin-GFP-transfected and anti-nestin-stained cells co-expressing GR are 
shown; also shown are images from the same sets of cells after staining of the cell nuclei with Hoechst 
dye 33342; arrowheads point to identical cells in each row.  (D) The dose-dependent induction of 
apoptosis by DEX is shown in the left-hand panel; these results are based on terminal deoxynucleotidyl 
transferase-mediated dUTP nick end-labeling (TUNEL) of apoptotic cells. Consistently robust 
responses are obtained at a dose of 10-5 M (used in all subsequent experiments). The right-hand panel 
shows that similar results are obtained when apoptosis is evaluated by either TUNEL histochemistry or 
immunocytochemistry for the active (cleaved) form of the executioner caspase, capsase 3. Note that the 
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apoptotic actions of DEX can be significantly attenuated by pretreatment (30 min) of cells with the GR 
antagonist RU38486 (10-5 M), indicating mediation by GR. All numerical data are depicted as mean ± 
SD. * P < 0.05 vs. CON, #  P < 0.05 vs. DEX. Scale bar = 50 µm in (A), 20 µm in (C). 
 
Fig 2.  Proliferating and resting cells are targets of GC-induced apoptosis.  
(A) Exposure of DIV7 hippocampal cultures to DEX (10-5 M) leads to a significant loss of NPC 
(nestin-positive) and immature neurons (DCX/TuJ1-positive). (B) and (C), Representative images of 
cells that were treated simultaneously with BrdU (20 µM) and DEX (10-5 M) before staining 24 h later for 
BrdU (to mark cells born in the preceding 24 h) and TUNEL. TUNEL-labeling is shown in control (B1) 
and DEX-treated cells (C1), respectively; panels B2-B5 and C2-C5 are higher magnifications of the 
areas marked by the dotted boxes in B1 and C1, respectively; B2 and C2 show apoptotic cells, B3 and 
C3 show BrdU-incorporating cells, and B4 and C4 show nuclear staining with Hoechst dye, in control 
and DEX-treated cells, respectively; panels B5 and C5 show merged images of B2-B4 and C2-C4, 
respectively. Arrowheads point to identical cells in each column and exemplify apoptosis 
(TUNEL-stained) in recently-proliferated cells (BrdU-stained). (D) Quantitative analysis of TUNEL 
staining in proliferative (BrdU+) and resting (BrdU-) cells. (E) Comparable data to those shown in (D) 
were obtained when cells were double-labeled for BrdU and cleaved (active) caspase 3. All numerical 
data are shown as mean ± SD. Asterisks indicate significant differences vs. control (untreated) cells (P < 
0.05). Scale bars: 20 µm.  
 
Fig 3.  Neural precursors and neuronal progenitors are driven into apoptosis by DEX. 
Cultures were transfected with either nestin-GFP or Tα-tubulin-GFP plasmids to label neural precursors 
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or neuronal progenitors, respectively. The percentage of cells staining positively for TUNEL or activated 
caspase 3 among the nestin- or Tα-tubulin-labeled populations were counted to examine how each 
phenotype was influenced by DEX. Representative images from TUNEL-stained cells that had been 
previously transfected with nestin-GFP (A-C and G-I) or Tα-tubulin-GFP (E-F and J-L); control cells are 
shown in A-C and D-F and DEX-treated cells are shown in G-I and J-L, where solid arrowheads 
indicate apoptotic GFP+ cells, detected by TUNEL and Hoechst staining. Examples of activated 
caspase 3 staining in specifically tagged NPC (nestin-GFP) and neuronal progenitor (Tα-tubulin-GFP) 
sub-populations are shown in M-T; open arrowheads indicate activated caspase3-/GFP+ cells and solid 
arrowheads point to activated caspase3+/GFP+ cells. Numerical analysis of these data is shown in U 
and V. Note that astrocytes labeled with GFAP-GFP do not undergo DEX-induced apoptosis (U).  All 
numerical data are given as mean ± SD. * P < 0.05 vs. CON, #  P < 0.05 vs. DEX. Scale bars: 20 µm.  
 
Fig 4. DEX induces NPC apoptosis by increasing ROS production, perturbation of the 
mitochondrial membrane potential and subsequently, activation of the intrinsic apoptotic 
pathway. 
(A) Pretreatment with either Ac-DEVD-cmk (caspase 3 inhibitor) or Ac-LEHD-cmk (caspase 9 inhibitor) 
rescue NPC from DEX-induced apoptosis. (B) Expression levels of Bcl-2 family members were 
measured by qPCR after exposure of cultures to various doses of DEX;  dose response curves, in terms 
of the ratio of pro-apoptotic bax to anti-apoptotic bcl-2 or bcl-xl, reveal that DEX first produces a 
significant increase in the bax:bcl-2 ratio at a dose of 10-5 M, and that ratio of bax:bcl-xl is not influenced 
by DEX treatment. (C) Treatment of NPC cultures with DEX (10-5 M ) stimulates ROS production, 
indicated by the intercalation of ethidum into DNA (red fluorescence). (D) Confirmation of 
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DEX-stimulated ROS production in identified NPC that were labeled with nestin-GFP. (E) Treatment of 
primary cultures with DEX increases ROS production, as measured by DHE staining; note NPC, 
marked with nestin-GFP also show significantly increased levels of ROS in response to DEX. (F) 
Immunostaining for the p47-phox, a subunit of nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase, showing localization of the signal from the cytoplasm to the plasma membrane (arrowheads) in 
NPC (identified by nestin immunostaining) after DEX treatment. (G) Treatment of cultures with DEX 
leads to significant reductions in two key anti-oxidant enzymes, glutathione (GSH) and superoxide 
dismutases (SOD); enzyme activities were normalized to protein concentrations of the cell extracts.  All 
numerical data are depicted as mean ± SD. * P < 0.05 vs. CON, #  P < 0.05 vs. DEX. Scale bar = 20 µm 
in C, 10 µm in D and F.  
 
Fig 5.  Neonatal GC treatment induces apoptosis in the SGZ in situ. 
(A) Immunohistochemistry for GR in the dentate gyrus of PND10 rats revealed a gradient of staining 
intensity, rising from the germinative subgranular zone (SGZ) to the granule cell layer (GCL); the area 
enclosed by the white box is enlarged in the inset, where the arrowheads mark examples of GR-positive 
NPC at the hilus-SGZ border. (B) and (C), Confocal images of activated caspase 3 immunostaining in a 
section from the dorsal portion of the dentate gyrus of a control (B) and a DEX-treated (C) rat (PND10); 
the arrowheads point to examples of cells showing immunoreactivity in the SGZ. (D) Numerical analysis 
of sections from control (n=7) and DEX-treated rats (n=8) stained for activated caspase 3 activity in SGZ; 
data shown are mean ± SEM. * P < 0.05 vs. CON. Scale bar: 1 mm in (A) and 20 µm in the inset of (A), 
(B) and (C). 
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Fig 6.  GC treatment in neonatal life results in a sustained reduction of neurogenic capacity.  
(A)-(C), Confocal images showing double staining with anti-BrdU (A) and anti-Ki67 (B). Arrowheads 
indicate cells co-labeled with the BrdU and Ki67 antibodies. Hoechst 33342 staining (C) was used to 
identify cell nuclei and to help delineate the SGZ and GCL. (D) DEX treatment (200 µg/kg/d on PND1-3, 
tapering to 100 µg/kg/d) on PND1-7 results in a significant reduction in the number of proliferating cells, 
as judged by immunostaining of BrdU-incorporating cells and Ki67-immunoreactive cells on PND10, 18 
and 28; note the progressive decline in proliferating cells in controls over the time period examined. (E) 
The volume of the SGZ and GCL of rats exposed to DEX on PND1-7 is significantly smaller when 
estimated on PND10 and 28. Note that the increase in GCL volume, between PND10 and PND28, was 
greater in controls than in neonatally DEX-treated rats. All numerical values are mean ± SEM. * P < 0.05, 
** P <0.01, as compared to age-matched controls; ##  indicates significant difference between P10 and 
P28 (P< 0.01). PND10, CON, n=7; DEX, n=8; PND 18, CON, n=8,; DEX, n=8; PND28, CON, n=8; DEX, 
n=9. Scale bar: 20 µm.  
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Fig 1.  Immature hippocampal cells are sensitive to glucocorticoids. 
(A) After 7 days in vitro (DIV), primary hippocampal cultures, derived from postnatal rats aged 4 
days, were comprised of ~ 40% neural precursor cells (NPC, labeled with anti-nestin) and ~ 35% 
immature neurons (stained with anti-TuJ1 or -doublecortin [DCX]; <10% of the cells stained with 
anti-NeuN, a marker of young neurons (NeuN), and <20% of the cells were astrocytes and 
oligodendrocytes (stained with antibody O4). (B) Immunoreactive glucocorticoid receptor (GR) was 
localized in both NPC and neuronal progenitors; shown are the percentage of GR in NPC (nestin-
positive cells identified by immunocytochemistry or cells transfected with nestin-GFP) and immature 
neurons (stained with anti-DCX or -TuJ1, or transfected with Tα-tubulin-GFP), as well as neurons 
(stained with anti-NeuN). The inset is an example of an immunoblot of cytoplasmic and nuclear 
fractions probed with GR antibody; note the increased GR signal in the nucleus (vs. cytoplasm) in 
lysates from cells that had been treated with glucocorticoid (dexamethasone, DEX, 10-5 M). (C) 
Representative images of nestin-GFP-transfected and anti-nestin-stained cells co-expressing GR are 
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shown; also shown are images from the same sets of cells after staining of the cell nuclei with 
Hoechst dye 33342; arrowheads point to identical cells in each row.  (D) The dose-dependent 
induction of apoptosis by DEX is shown in the left-hand panel; these results are based on terminal 
deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) of apoptotic cells. 
Consistently robust responses are obtained at a dose of 10-5 M (used in all subsequent 
experiments). The right-hand panel shows that similar results are obtained when apoptosis is 
evaluated by either TUNEL histochemistry or immunocytochemistry for the active (cleaved) form of 
the executioner caspase, capsase 3. Note that the apoptotic actions of DEX can be significantly 
attenuated by pretreatment (30 min) of cells with the GR antagonist RU38486 (10-5 M), indicating 
mediation by GR. All numerical data are depicted as mean ± SD. * P < 0.05 vs. CON, #  P < 0.05 
vs. DEX. Scale bar = 50 µm in (A), 20 µm in (C). 
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Fig 2.  Proliferating and resting cells are targets of GC-induced apoptosis.  
(A) Exposure of DIV7 hippocampal cultures to DEX (10-5 M) leads to a significant loss of NPC 
(nestin-positive) and immature neurons (DCX/TuJ1-positive). (B) and (C), Representative images of 
cells that were treated simultaneously with BrdU (20 µM) and DEX (10-5 M) before staining 24 h 
later for BrdU (to mark cells born in the preceding 24 h) and TUNEL. TUNEL-labeling is shown in 
control (B1) and DEX-treated cells (C1), respectively; panels B2-B5 and C2-C5 are higher 
magnifications of the areas marked by the dotted boxes in B1 and C1, respectively; B2 and C2 show 
apoptotic cells, B3 and C3 show BrdU-incorporating cells, and B4 and C4 show nuclear staining with 
Hoechst dye, in control and DEX-treated cells, respectively; panels B5 and C5 show merged images 
of B2-B4 and C2-C4, respectively. Arrowheads point to identical cells in each column and exemplify 
apoptosis (TUNEL-stained) in recently-proliferated cells (BrdU-stained). (D) Quantitative analysis of 
TUNEL staining in proliferative (BrdU+) and resting (BrdU-) cells. (E) Comparable data to those 
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shown in (c) were obtained when cells were double-labeled for BrdU and cleaved (active) caspase 3. 
All numerical data are shown as mean ± SD. Asterisks indicate significant differences vs. control 
(untreated) cells (P < 0.05). Scale bars: 20 µm.  
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Fig 3.  Neural precursors and neuronal progenitors are driven into apoptosis by DEX. 
Cultures were transfected with either nestin-GFP or Tα-tubulin-GFP plasmids to label neural 
precursors or neuronal progenitors, respectively. The percentage of cells staining positively for 
TUNEL or activated caspase 3 among the nestin- or Tα-tubulin-labeled populations were counted to 
examine how each phenotype was influenced by DEX. Representative images from TUNEL-stained 
cells that had been previously transfected with nestin-GFP (A-C and G-I) or Tα-tubulin-GFP (E-F and 
J-L); control cells are shown in A-C and D-F and DEX-treated cells are shown in G-I and J-L, where 
solid arrowheads indicate apoptotic GFP+ cells, detected by TUNEL and Hoechst staining. Examples 
of activated caspase 3 staining in specifically tagged NPC (nestin-GFP) and neuronal progenitor (Tα-
tubulin-GFP) sub-populations are shown in M-T; open arrowheads indicate activated caspase3-
/GFP+ cells and solid arrowheads point to activated caspase3+/GFP+ cells. Numerical analysis of 
these data is shown in U and V. Note that astrocytes labeled with GFAP-GFP do not undergo DEX-
induced apoptosis (U).  All numerical data are given as mean ± SD. * P < 0.05 vs. CON, #  P < 
0.05 vs. DEX. Scale bars: 20 µm.  
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Fig 4. DEX induces NPC apoptosis by increasing ROS production, perturbation of the mitochondrial 
membrane potential and subsequently, activation of the intrinsic apoptotic pathway. 
(A) Pretreatment with either Ac-DEVD-cmk (caspase 3 inhibitor) or Ac-LEHD-cmk (caspase 9 
inhibitor) rescue NPC from DEX-induced apoptosis. (B) Expression levels of Bcl-2 family members 
were measured by qPCR after exposure of cultures to various doses of DEX;  dose response curves, 
in terms of the ratio of pro-apoptotic bax to anti-apoptotic bcl-2 or bcl-xl, reveal that DEX first 
produces a significant increase in the bax:bcl-2 ratio at a dose of 10-5 M, and that ratio of bax:bcl-
xl is not influenced by DEX treatment. (C) Treatment of NPC cultures with DEX (10-5 M ) stimulates 
ROS production, indicated by the intercalation of ethidum into DNA (red fluorescence). (D) 
Confirmation of DEX-stimulated ROS production in identified NPC that were labeled with nestin-GFP. 
(E) Treatment of primary cultures with DEX increases ROS production, as measured by DHE 
staining; note NPC, marked with nestin-GFP also show significantly increased levels of ROS in 
response to DEX. (F) Immunostaining for the p47-phox, a subunit of nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase, showing localization of the signal from the cytoplasm to 
the plasma membrane (arrowheads) in NPC (identified by nestin immunostaining) after DEX 
treatment. (G) Treatment of cultures with DEX leads to significant reductions in two key anti-
oxidant enzymes, glutathione (GSH) and superoxide dismutases (SOD); enzyme activities were 
normalized to protein concentrations of the cell extracts.  All numerical data are depicted as mean ± 
SD. * P < 0.05 vs. CON, #  P < 0.05 vs. DEX. Scale bar = 20 µm in C, 10 µm in D and F. 
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Fig 5.  Neonatal GC treatment induces apoptosis in the SGZ in situ. 
(A) Immunohistochemistry for GR in the dentate gyrus of PND10 rats revealed a gradient of staining 
intensity, rising from the germinative subgranular zone (SGZ) to the granule cell layer (GCL); the 
area enclosed by the white box is enlarged in the inset, where the arrowheads mark examples of 
GR-positive NPC at the hilus-SGZ border. (B) and (C), Confocal images of activated caspase 3 
immunostaining in a section from the dorsal portion of the dentate gyrus of a control (B) and a 
DEX-treated (C) rat (PND10); the arrowheads point to examples of cells showing immunoreactivity 
in the SGZ. (D) Numerical analysis of sections from control (n=7) and DEX-treated rats (n=8) 
stained for activated caspase 3 activity in SGZ; data shown are mean ± SEM. * P < 0.05 vs. CON. 
Scale bar: 1 mm in (A) and 20 µm in the inset of (A), (B) and (C). 
 
70x45mm (600 x 600 DPI)  
 
Page 31 of 32
John Wiley & Sons
Annals of Neurology
   
 
 
Fig 6.  GC treatment in neonatal life results in a sustained reduction of neurogenic capacity.  
(A)-(C), Confocal images showing double staining with anti-BrdU (A) and anti-Ki67 (B). Arrowheads 
indicate cells co-labeled with the BrdU and Ki67 antibodies. Hoechst 33342 staining (C) was used to 
identify cell nuclei and to help delineate the SGZ and GCL. (D) DEX treatment (200 µg/kg/d on 
PND1-3, tapering to 100 µg/kg/d) on PND1-7 results in a significant reduction in the number of 
proliferating cells, as judged by immunostaining of BrdU-incorporating cells and Ki67-
immunoreactive cells on PND10, 18 and 28; note the progressive decline in proliferating cells in 
controls over the time period examined. (E) The volume of the SGZ and GCL of rats exposed to DEX 
on PND1-7 is significantly smaller when estimated on PND10 and 28. Note that the increase in GCL 
volume, between PND10 and PND28, was greater in controls than in neonatally DEX-treated rats. All 
numerical values are mean ± SEM. * P < 0.05, ** P <0.01, as compared to age-matched controls; 
##  indicates significant difference between P10 and P28 (P< 0.01). PND10, CON, n=7; DEX, n=8; 
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SUPPLEMENTARY INFORMATION 
 
Yu et al. Depletion of the neural precursor cell pool by glucocorticoids  
 
Supplementary Methods 
Reactive oxygen species (ROS) generation: ROS generation was assayed by allowing 
dihydroethidium (DHE; 5 µM) to react (30 min; 37°C) with cellular superoxide ions, to yield red 
fluorescent ethidium. Cells were then washed and fixed in 4% PFA before observation under a 
microscope (excitation, 520nm; emission, 590nm).  
 
GSH and SOD assays: Glutathione (GSH) and superoxide dismutase (SOD) activity were measured 
using commercial GSH and SOD assay kits (Cayman Chemical, Tallinn, Estonia). Enzyme activities 
were corrected for protein concentration in the test samples. 
 
Quantitative-PCR: Total RNA was isolated (RNAeasy kit; Qiagen, Hilden, Germany) and reverse 
transcribed with SUPERSCRIPTTM II RNA H-reverse transcriptase (Invitrogen) with custom-
synthesized Oligo-dT12-18 primers (MWG Biotech, Ebersberg, Germany). Quantitative PCR (qPCR) 
was performed using a LightCycler (Roche Diagnostics, Mannheim, Germany) in a volume of 10 µl 
containing 2 µl of 5x Faststart DNA SYBR green I (Roche) master mix,, 5 µl of water, 0.5 µl of each 
primer, and 2 µl of extracted DNA. Initial denaturation was carried out at 95°C (slope, 20°C/s) for 10 
min, followed by 40 cycles of denaturation at 94°C (5 s); annealing temperatures (5 s) were 63°C (for 
bcl-xL, bcl-2) and 64°C (for Bax and HPRT1), with an additional 10 s at 72°C. The specific 5’-3’ primer 
pair sequences were: Bax (174 bp), forward CTGCAGAGGATGATTGCTGA and reverse 
GATCAGCTCGGGCACTTTAG; bcl-xL (121bp), forward GATCAGCTCGGGCACTTTAG and reverse 
CAGGAACCAGCGGTTGAAA; bcl-2 (251bp), forward CGGTGGTGGAGGAACTCTTC and reverse 
CAGCCAGGAGAAATCAAACAGA; HPRT1 (203 bp), forward GGACCTCTCGAAGTGTTGGA and 
reverse GGCCACATCAACAGGACTCT. All calculations and statistical analyses were based on 
relative expression levels of the the mRNA of interest to levels of mRNA coding for the housekeeping 
gene HPRT1. 
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Supplementary legends 
Fig S1. Quiescent neural progenitor (QNP) and amplifying neural progenitor (ANP) cells 
express GR.  
(A) Double immunostaining for nestin and GR in the subgranular zone (SGZ) of the dentate gyrus 
(PND6) revealed GR expression in nestin-positive NPCs; arrowheads indicate examples of cells 
showing both nestin and GR immunoreactivity. (B) Demonstration of colocalization of GR in GFAP- 
and Sox2-positive cells within the dentate gyrus. The area enclosed by the white box is enlarged and 
shown in the right panel (B1 shows GFAP-, B2 shows GR-, B3 shows Sox2- immunostaining; B4 
shows merged images). Hoechst staining was used to define the position of immunopositive cells. 
Open arrowheads indicate GR expression in ANP (GFAP-Sox2+), and solid arrowheads indicate GR 
expression in the QNP (GFAP+Sox2+). (C) Numerical representation of relative numbers of QNP and 
ANP cells that express GR; note the comparable expression of GR in both cell types. Data shown are 
mean ± SD. Scale bar: 20µm in (A), (B1-B4) and 50 µm in (B). 
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Fig S1. Quiescent neural progenitor (QNP) and amplifying neural progenitor (ANP) cells express GR. 
(A) Double immunostaining for nestin and GR in the subgranular zone (SGZ) of the dentate gyrus 
(PND6) revealed GR expression in nestin-positive NPCs; arrowheads indicate examples of cells 
showing both nestin and GR immunoreactivity. (B) Demonstration of colocalization of GR in GFAP- 
and Sox2-positive cells within the dentate gyrus. The area enclosed by the white box is enlarged 
and shown in the right panel (B1 shows GFAP-, B2 shows GR-, B3 shows Sox2- immunostaining; B4 
shows merged images). Hoechst staining was used to define the position of immunopositive cells. 
Open arrowheads indicate GR expression in ANP (GFAP-Sox2+), and solid arrowheads indicate GR 
expression in the QNP (GFAP+Sox2+). (C) Numerical representation of relative numbers of QNP and 
ANP cells that express GR; note the comparable expression of GR in both cell types. Data shown are 
mean ± SD. Scale bar: 20µm in (A), (B1-B4) and 50 µm in (B). 
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